+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Single Use Immunoadsorption Column Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6078958
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Single Use Immunoadsorption Column Market is projected to reach USD 359.48 Million in 2026. It is expected to continue growing at a CAGR of 6.81%, reaching USD 528.84 Million by 2032.

Single-Use Immunoadsorption Columns: Executive Overview

Single-use immunoadsorption columns are disposable extracorporeal devices designed to remove targeted antibodies or immune complexes from blood or plasma. Their relevance is linked to applications in autoimmune disorders, transplant medicine, antibody-mediated complications, and selected acute-care protocols. Adoption depends on clinical evidence, treatment guidelines, reimbursement, compatibility with apheresis systems, operator training, and the availability of validated supply chains.

Clinical Workflow and Manufacturing Shifts Reshaping Adoption

The landscape is shifting toward disposable, traceable, and workflow-integrated treatment components. Hospitals and apheresis centers increasingly evaluate columns on selectivity, hemocompatibility, priming requirements, connection standards, storage conditions, waste handling, and consistency between treatment sessions. Greater emphasis on infection-control procedures and reduced reprocessing burden supports single-use designs, while regulatory scrutiny requires robust validation of materials, performance, sterility, and lot-to-lot quality.

Artificial Intelligence Strengthens Selection, Monitoring, and Evidence Generation

Artificial intelligence can support patient selection by combining clinical, laboratory, immunological, and treatment-response data, although clinical decisions require physician oversight and validated protocols. During procedures, machine-learning tools may help identify abnormal pressure trends, detect changes in treatment performance, and improve documentation. AI also enables structured analysis of real-world evidence, but its use must address data quality, explainability, cybersecurity, privacy, algorithmic bias, and compliance with medical-device and clinical-governance requirements.

Regional Insights: Regulation, Infrastructure, and Access Shape Use

North America benefits from advanced apheresis infrastructure and substantial specialist capacity, while evidence requirements, reimbursement policies, and hospital procurement standards influence implementation. Latin America shows opportunity where tertiary-care networks and specialist training are available, but access can be constrained by import procedures, funding, and uneven infrastructure. Europe is shaped by harmonized regulatory expectations, country-level reimbursement, and established transplant and autoimmune-care pathways. The Middle East is developing specialist hospital capacity, with adoption concentrated in well-equipped referral centers. Africa remains highly heterogeneous, with limited apheresis availability in many settings and a need for training, maintenance support, and dependable logistics. Asia-Pacific combines sophisticated care systems in several markets with substantial variation in reimbursement, regulatory processes, and access across emerging healthcare networks.

Group Insights: Economic and Security Blocs Influence Procurement Conditions

ASEAN countries may benefit from regional healthcare cooperation, but regulatory pathways and clinical capacity remain diverse. BRICS members present broad healthcare needs alongside differing reimbursement systems, domestic manufacturing capabilities, and access to specialist services. The European Union emphasizes regulatory conformity, clinical evidence, sustainability, and cross-border healthcare considerations. G7 systems generally apply rigorous evidence, safety, procurement, and health-technology-assessment standards. GCC countries often concentrate advanced extracorporeal care in highly equipped referral hospitals and may prioritize technology transfer and specialist partnerships. NATO members collectively include mature medical infrastructures but retain country-specific rules for procurement, reimbursement, and clinical practice.

Country Insights: National Care Pathways Determine Implementation

Australia combines specialist hospital capacity with geographically dispersed care, making logistics and referral coordination important. Brazil’s large and varied healthcare system creates differences between advanced centers and lower-resource settings. Canada’s implementation is influenced by provincial funding, centralized procurement, and specialist availability. China is expanding advanced clinical capabilities while navigating domestic regulatory and procurement requirements. France, Germany, Italy, and Spain have established hospital and apheresis expertise, but adoption is affected by national reimbursement, evidence expectations, and institutional protocols. India’s access is concentrated in leading hospitals, with affordability, training, and regional infrastructure remaining central considerations. Japan and South Korea maintain sophisticated hospital systems with strong quality requirements and structured regulatory oversight. Mexico’s tertiary-care network supports use in selected centers, while access and reimbursement vary. Russia’s implementation is shaped by specialist-center availability, procurement conditions, and regulatory requirements. The United Kingdom evaluates adoption through national clinical guidance, procurement, and evidence frameworks. The United States is influenced by specialist capacity, payer policy, hospital economics, and regulatory compliance.

Actionable Priorities for Leaders in Immunoadsorption Care

Industry leaders should prioritize well-designed clinical studies that connect immunological endpoints with meaningful patient outcomes and clearly defined treatment protocols. Product development should focus on reliable selectivity, hemocompatibility, compatibility with commonly used systems, simple handling, and transparent instructions for use. Organizations should build evidence packages suited to regulators, health-technology-assessment bodies, clinicians, and procurement teams rather than relying on technical claims alone. Regional strategies should include local training, service support, inventory planning, and partnerships with qualified referral centers. Data programs should use AI cautiously, with human oversight, validation, cybersecurity controls, and auditable governance. Sustainability efforts should address materials, packaging, transport, and compliant disposal without compromising sterility or safety.

Research Methodology for the Executive Summary

This summary uses a structured qualitative synthesis of the defined single-use immunoadsorption column category, focusing on clinical use, device characteristics, healthcare delivery, regulation, procurement, infrastructure, and technology adoption. Regional, group, and country perspectives are organized around publicly observable healthcare-system factors rather than unsupported numerical claims. The assessment distinguishes established considerations from implementation opportunities and constraints, excludes market estimates and company-specific claims, and treats artificial intelligence as an enabling technology requiring clinical and regulatory validation. Findings should be complemented by current national guidance, device-label information, peer-reviewed evidence, reimbursement rules, and institution-specific protocols before operational decisions are made.

Conclusion: Evidence-Led Expansion Depends on Safe, Integrated Delivery

Single-use immunoadsorption columns address a specialized need within extracorporeal and immune-mediated care. Their successful implementation depends less on device availability alone than on coordinated evidence generation, patient selection, trained personnel, compatible infrastructure, reimbursement, supply reliability, and regulatory compliance. Leaders that integrate product quality with clinical education, responsible data use, and region-specific implementation planning will be better positioned to support safe and consistent adoption across diverse healthcare systems.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Single Use Immunoadsorption Column Market, by Product Type
7.1. Introduction
7.2. Immunoglobulin Adsorption Column
7.2.1. IgG-Focused Column
7.2.2. Broad-Spectrum Immunoglobulin Column
7.2.3. Selective Autoantibody Column
7.3. Immune Complex Adsorption Column
7.3.1. Circulating Immune Complex Column
7.3.2. Complement-Immune Complex Column
7.4. Lipoprotein Adsorption Column
7.4.1. Low-Density Lipoprotein Column
7.4.2. Mixed Lipoprotein Column
7.5. Cytokine Adsorption Column
7.6. Multi-Target Adsorption Column
8. Single Use Immunoadsorption Column Market, by Ligand Type
8.1. Introduction
8.2. Antibody Specific
8.3. Protein A
8.4. Protein G
9. Single Use Immunoadsorption Column Market, by Material Type
9.1. Introduction
9.2. Agarose
9.3. Cellulose
9.4. Synthetic Polymer
10. Single Use Immunoadsorption Column Market, by Application
10.1. Introduction
10.2. Multiple Sclerosis
10.3. Rheumatoid Arthritis
10.4. Systemic Lupus Erythematosus
11. Single Use Immunoadsorption Column Market, by End User
11.1. Introduction
11.2. Hospitals
11.2.1. Private Hospitals
11.2.1.1. Charity Run
11.2.1.2. Profit Run
11.2.2. Public Hospitals
11.2.2.1. Government Run
11.2.2.2. University Affiliated
11.3. Research Institutes
11.3.1. Academic Institutes
11.3.2. Contract Research Organizations
11.4. Specialized Clinics
11.4.1. Autoimmune Clinics
11.4.2. Plasma Exchange Centers
12. Single Use Immunoadsorption Column Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Single Use Immunoadsorption Column Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Single Use Immunoadsorption Column Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Agilent Technologies, Inc.
16.2. Asahi Kasei Medical Co., Ltd.
16.3. Avantor, Inc.
16.4. Bio-Rad Laboratories, Inc.
16.5. Corning Incorporated
16.6. Danaher Corporation
16.7. Eppendorf AG
16.8. Fresenius Medical Care AG & Co. KGaA
16.9. Fujifilm Diosynth Biotechnologies
16.10. GE Healthcare
16.11. Jafron Biomedical Co., Ltd.
16.12. Merck KGaA
16.13. POCARD Ltd.
16.14. Repligen Corporation
16.15. Sartorius AG
16.16. Thermo Fisher Scientific Inc.
16.17. Tosoh Corporation
16.18. Waters Corporation
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Single Use Immunoadsorption Column Market, Years Considered for the Study
FIGURE 2. Global Single Use Immunoadsorption Column Market, Research Design
FIGURE 3. Global Single Use Immunoadsorption Column Market, Research Framework
FIGURE 4. Global Single Use Immunoadsorption Column Market, Data Triangulation
FIGURE 5. Global Single Use Immunoadsorption Column Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Single Use Immunoadsorption Column Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Single Use Immunoadsorption Column Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Single Use Immunoadsorption Column Market Size, by Ligand Type, 2025 vs 2032 (%)
FIGURE 9. Global Single Use Immunoadsorption Column Market Size, by Ligand Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Single Use Immunoadsorption Column Market Size, by Material Type, 2025 vs 2032 (%)
FIGURE 11. Global Single Use Immunoadsorption Column Market Size, by Material Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Single Use Immunoadsorption Column Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Single Use Immunoadsorption Column Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Single Use Immunoadsorption Column Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Single Use Immunoadsorption Column Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Single Use Immunoadsorption Column Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Single Use Immunoadsorption Column Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Single Use Immunoadsorption Column Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Single Use Immunoadsorption Column Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Single Use Immunoadsorption Column Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Single Use Immunoadsorption Column Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Single Use Immunoadsorption Column Market Segmentation & Coverage
TABLE 2. Global Single Use Immunoadsorption Column Market Size, 2017-2032 (USD Million)
TABLE 3. Global Single Use Immunoadsorption Column Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Immunoglobulin Adsorption Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Immunoglobulin Adsorption Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Immunoglobulin Adsorption Column Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global IgG-Focused Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global IgG-Focused Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global IgG-Focused Column Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Broad-Spectrum Immunoglobulin Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Broad-Spectrum Immunoglobulin Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Broad-Spectrum Immunoglobulin Column Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Selective Autoantibody Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Selective Autoantibody Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Selective Autoantibody Column Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Immune Complex Adsorption Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Immune Complex Adsorption Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Immune Complex Adsorption Column Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Circulating Immune Complex Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Circulating Immune Complex Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Circulating Immune Complex Column Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Complement-Immune Complex Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Complement-Immune Complex Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Complement-Immune Complex Column Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Lipoprotein Adsorption Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Lipoprotein Adsorption Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Lipoprotein Adsorption Column Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Low-Density Lipoprotein Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Low-Density Lipoprotein Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Low-Density Lipoprotein Column Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Mixed Lipoprotein Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Mixed Lipoprotein Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Mixed Lipoprotein Column Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Cytokine Adsorption Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Cytokine Adsorption Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Cytokine Adsorption Column Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Multi-Target Adsorption Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Multi-Target Adsorption Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Multi-Target Adsorption Column Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Single Use Immunoadsorption Column Market Size, by Ligand Type, 2017-2032 (USD Million)
TABLE 41. Global Antibody Specific Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Antibody Specific Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Antibody Specific Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Protein A Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Protein A Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Protein A Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Protein G Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Protein G Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Protein G Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Single Use Immunoadsorption Column Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 51. Global Agarose Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Agarose Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Agarose Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Cellulose Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Cellulose Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Cellulose Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Synthetic Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Synthetic Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Synthetic Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Single Use Immunoadsorption Column Market Size, by Application, 2017-2032 (USD Million)
TABLE 61. Global Multiple Sclerosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Multiple Sclerosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Multiple Sclerosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Rheumatoid Arthritis Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Rheumatoid Arthritis Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Rheumatoid Arthritis Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Systemic Lupus Erythematosus Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Systemic Lupus Erythematosus Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Systemic Lupus Erythematosus Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Single Use Immunoadsorption Column Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Charity Run Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Charity Run Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Charity Run Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Profit Run Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Profit Run Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Profit Run Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Government Run Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Government Run Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Government Run Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global University Affiliated Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global University Affiliated Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global University Affiliated Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Academic Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Academic Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Academic Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Specialized Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Specialized Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Specialized Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Autoimmune Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Autoimmune Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Autoimmune Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Plasma Exchange Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Plasma Exchange Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Plasma Exchange Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Single Use Immunoadsorption Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Single Use Immunoadsorption Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Single Use Immunoadsorption Column Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Single Use Immunoadsorption Column Market Size, by Immunoglobulin Adsorption Column, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Single Use Immunoadsorption Column Market Size, by Immune Complex Adsorption Column, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Single Use Immunoadsorption Column Market Size, by Lipoprotein Adsorption Column, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific Single Use Immunoadsorption Column Market Size, by Ligand Type, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific Single Use Immunoadsorption Column Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific Single Use Immunoadsorption Column Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Single Use Immunoadsorption Column Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Single Use Immunoadsorption Column Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific Single Use Immunoadsorption Column Market Size, by Private Hospitals, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Single Use Immunoadsorption Column Market Size, by Public Hospitals, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Single Use Immunoadsorption Column Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Single Use Immunoadsorption Column Market Size, by Specialized Clinics, 2017-2032 (USD Million)
TABLE 125. North America Single Use Immunoadsorption Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. North America Single Use Immunoadsorption Column Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. North America Single Use Immunoadsorption Column Market Size, by Immunoglobulin Adsorption Column, 2017-2032 (USD Million)
TABLE 128. North America Single Use Immunoadsorption Column Market Size, by Immune Complex Adsorption Column, 2017-2032 (USD Million)
TABLE 129. North America Single Use Immunoadsorption Column Market Size, by Lipoprotein Adsorption Column, 2017-2032 (USD Million)
TABLE 130. North America Single Use Immunoadsorption Column Market Size, by Ligand Type, 2017-2032 (USD Million)
TABLE 131. North America Single Use Immunoadsorption Column Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 132. North America Single Use Immunoadsorption Column Market Size, by Application, 2017-2032 (USD Million)
TABLE 133. North America Single Use Immunoadsorption Column Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. North America Single Use Immunoadsorption Column Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 135. North America Single Use Immunoadsorption Column Market Size, by Private Hospitals, 2017-2032 (USD Million)
TABLE 136. North America Single Use Immunoadsorption Column Market Size, by Public Hospitals, 2017-2032 (USD Million)
TABLE 137. North America Single Use Immunoadsorption Column Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 138. North America Single Use Immunoadsorption Column Market Size, by Specialized Clinics, 2017-2032 (USD Million)
TABLE 139. Latin America Single Use Immunoadsorption Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Latin America Single Use Immunoadsorption Column Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 141. Latin America Single Use Immunoadsorption Column Market Size, by Immunoglobulin Adsorption Column, 2017-2032 (USD Million)
TABLE 142. Latin America Single Use Immunoadsorption Column Market Size, by Immune Complex Adsorption Column, 2017-2032 (USD Million)
TABLE 143. Latin America Single Use Immunoadsorption Column Market Size, by Lipoprotein Adsorption Column, 2017-2032 (USD Million)
TABLE 144. Latin America Single Use Immunoadsorption Column Market Size, by Ligand Type, 2017-2032 (USD Million)
TABLE 145. Latin America Single Use Immunoadsorption Column Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 146. Latin America Single Use Immunoadsorption Column Market Size, by Application, 2017-2032 (USD Million)
TABLE 147. Latin America Single Use Immunoadsorption Column Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. Latin America Single Use Immunoadsorption Column Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 149. Latin America Single Use Immunoadsorption Column Market Size, by Private Hospitals, 2017-2032 (USD Million)
TABLE 150. Latin America Single Use Immunoadsorption Column Market Size, by Public Hospitals, 2017-2032 (USD Million)
TABLE 151. Latin America Single Use Immunoadsorption Column Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 152. Latin America Single Use Immunoadsorption Column Market Size, by Specialized Clinics, 2017-2032 (USD Million)
TABLE 153. Europe Single Use Immunoadsorption Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Europe Single Use Immunoadsorption Column Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 155. Europe Single Use Immunoadsorption Column Market Size, by Immunoglobulin Adsorption Column, 2017-2032 (USD Million)
TABLE 156. Europe Single Use Immunoadsorption Column Market Size, by Immune Complex Adsorption Column, 2017-2032 (USD Million)
TABLE 157. Europe Single Use Immunoadsorption Column Market Size, by Lipoprotein Adsorption Column, 2017-2032 (USD Million)
TABLE 158. Europe Single Use Immunoadsorption Column Market Size, by Ligand Type, 2017-2032 (USD Million)
TABLE 159. Europe Single Use Immunoadsorption Column Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 160. Europe Single Use Immunoadsorption Column Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. Europe Single Use Immunoadsorption Column Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. Europe Single Use Immunoadsorption Column Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 163. Europe Single Use Immunoadsorption Column Market Size, by Private Hospitals, 2017-2032 (USD Million)
TABLE 164. Europe Single Use Immunoadsorption Column Market Size, by Public Hospitals, 2017-2032 (USD Million)
TABLE 165. Europe Single Use Immunoadsorption Column Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 166. Europe Single Use Immunoadsorption Column Market Size, by Specialized Clinics, 2017-2032 (USD Million)
TABLE 167. Middle East Single Use Immunoadsorption Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Middle East Single Use Immunoadsorption Column Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 169. Middle East Single Use Immunoadsorption Column Market Size, by Immunoglobulin Adsorption Column, 2017-2032 (USD Million)
TABLE 170. Middle East Single Use Immunoadsorption Column Market Size, by Immune Complex Adsorption Column, 2017-2032 (USD Million)
TABLE 171. Middle East Single Use Immunoadsorption Column Market Size, by Lipoprotein Adsorption Column, 2017-2032 (USD Million)
TABLE 172. Middle East Single Use Immunoadsorption Column Market Size, by Ligand Type, 2017-2032 (USD Million)
TABLE 173. Middle East Single Use Immunoadsorption Column Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 174. Middle East Single Use Immunoadsorption Column Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. Middle East Single Use Immunoadsorption Column Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. Middle East Single Use Immunoadsorption Column Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 177. Middle East Single Use Immunoadsorption Column Market Size, by Private Hospitals, 2017-2032 (USD Million)
TABLE 178. Middle East Single Use Immunoadsorption Column Market Size, by Public Hospitals, 2017-2032 (USD Million)
TABLE 179. Middle East Single Use Immunoadsorption Column Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 180. Middle East Single Use Immunoadsorption Column Market Size, by Specialized Clinics, 2017-2032 (USD Million)
TABLE 181. Africa Single Use Immunoadsorption Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 182. Africa Single Use Immunoadsorption Column Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. Africa Single Use Immunoadsorption Column Market Size, by Immunoglobulin Adsorption Column, 2017-2032 (USD Million)
TABLE 184. Africa Single Use Immunoadsorption Column Market Size, by Immune Complex Adsorption Column, 2017-2032 (USD Million)
TABLE 185. Africa Single Use Immunoadsorption Column Market Size, by Lipoprotein Adsorption Column, 2017-2032 (USD Million)
TABLE 186. Africa Single Use Immunoadsorption Column Market Size, by Ligand Type, 2017-2032 (USD Million)
TABLE 187. Africa Single Use Immunoadsorption Column Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 188. Africa Single Use Immunoadsorption Column Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. Africa Single Use Immunoadsorption Column Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. Africa Single Use Immunoadsorption Column Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 191. Africa Single Use Immunoadsorption Column Market Size, by Private Hospitals, 2017-2032 (USD Million)
TABLE 192. Africa Single Use Immunoadsorption Column Market Size, by Public Hospitals, 2017-2032 (USD Million)
TABLE 193. Africa Single Use Immunoadsorption Column Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 194. Africa Single Use Immunoadsorption Column Market Size, by Specialized Clinics, 2017-2032 (USD Million)
TABLE 195. Global Single Use Immunoadsorption Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 196. ASEAN Single Use Immunoadsorption Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 197. ASEAN Single Use Immunoadsorption Column Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 198. ASEAN Single Use Immunoadsorption Column Market Size, by Immunoglobulin Adsorption Column, 2017-2032 (USD Million)
TABLE 199. ASEAN Single Use Immunoadsorption Column Market Size, by Immune Complex Adsorption Column, 2017-2032 (USD Million)
TABLE 200. ASEAN Single Use Immunoadsorption Column Market Size, by Lipoprotein Adsorption Column, 2017-2032 (USD Million)
TABLE 201. ASEAN Single Use Immunoadsorption Column Market Size, by Ligand Type, 2017-2032 (USD Million)
TABLE 202. ASEAN Single Use Immunoadsorption Column Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 203. ASEAN Single Use Immunoadsorption Column Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. ASEAN Single Use Immunoadsorption Column Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. ASEAN Single Use Immunoadsorption Column Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 206. ASEAN Single Use Immunoadsorption Column Market Size, by Private Hospitals, 2017-2032 (USD Million)
TABLE 207. ASEAN Single Use Immunoadsorption Column Market Size, by Public Hospitals, 2017-2032 (USD Million)
TABLE 208. ASEAN Single Use Immunoadsorption Column Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 209. ASEAN Single Use Immunoadsorption Column Market Size, by Specialized Clinics, 2017-2032 (USD Million)
TABLE 210. GCC Single Use Immunoadsorption Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. GCC Single Use Immunoadsorption Column Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 212. GCC Single Use Immunoadsorption Column Market Size, by Immunoglobulin Adsorption Column, 2017-2032 (USD Million)
TABLE 213. GCC Single Use Immunoadsorption Column Market Size, by Immune Complex Adsorption Column, 2017-2032 (USD Million)
TABLE 214. GCC Single Use Immunoadsorption Column Market Size, by Lipoprotein Adsorption Column, 2017-2032 (USD Million)
TABLE 215. GCC Single Use Immunoadsorption Column Market Size, by Ligand Type, 2017-2032 (USD Million)
TABLE 216. GCC Single Use Immunoadsorption Column Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 217. GCC Single Use Immunoadsorption Column Market Size, by Application, 2017-2032 (USD Million)
TABLE 218. GCC Single Use Immunoadsorption Column Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. GCC Single Use Immunoadsorption Column Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 220. GCC Single Use Immunoadsorption Column Market Size, by Private Hospitals, 2017-2032 (USD Million)
TABLE 221. GCC Single Use Immunoadsorption Column Market Size, by Public Hospitals, 2017-2032 (USD Million)
TABLE 222. GCC Single Use Immunoadsorption Column Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 223. GCC Single Use Immunoadsorption Column Market Size, by Specialized Clinics, 2017-2032 (USD Million)
TABLE 224. European Union Single Use Immunoadsorption Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 225. European Union Single Use Immunoadsorption Column Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 226. European Union Single Use Immunoadsorption Column Market Size, by Immunoglobulin Adsorption Column, 2017-2032 (USD Million)
TABLE 227. European Union Single Use Immunoadsorption Column Market Size, by Immune Complex Adsorption Column, 2017-2032 (USD Million)
TABLE 228. European Union Single Use Immunoadsorption Column Market Size, by Lipoprotein Adsorption Column, 2017-2032 (USD Million)
TABLE 229. European Union Single Use Immunoadsorption Column Market Size, by Ligand Type, 2017-2032 (USD Million)
TABLE 230. European Union Single Use Immunoadsorption Column Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 231. European Union Single Use Immunoadsorption Column Market Size, by Application, 2017-2032 (USD Million)
TABLE 232. European Union Single Use Immunoadsorption Column Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. European Union Single Use Immunoadsorption Column Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 234. European Union Single Use Immunoadsorption Column Market Size, by Private Hospitals, 2017-2032 (USD Million)
TABLE 235. European Union Single Use Immunoadsorption Column Market Size, by Public Hospitals, 2017-2032 (USD Million)
TABLE 236. European Union Single Use Immunoadsorption Column Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 237. European Union Single Use Immunoadsorption Column Market Size, by Specialized Clinics, 2017-2032 (USD Million)
TABLE 238. BRICS Single Use Immunoadsorption Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 239. BRICS Single Use Immunoadsorption Column Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 240. BRICS Single Use Immunoadsorption Column Market Size, by Immunoglobulin Adsorption Column, 2017-2032 (USD Million)
TABLE 241. BRICS Single Use Immunoadsorption Column Market Size, by Immune Complex Adsorption Column, 2017-2032 (USD Million)
TABLE 242. BRICS Single Use Immunoadsorption Column Market Size, by Lipoprotein Adsorption Column, 2017-2032 (USD Million)
TABLE 243. BRICS Single Use Immunoadsorption Column Market Size, by Ligand Type, 2017-2032 (USD Million)
TABLE 244. BRICS Single Use Immunoadsorption Column Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 245. BRICS Single Use Immunoadsorption Column Market Size, by Application, 2017-2032 (USD Million)
TABLE 246. BRICS Single Use Immunoadsorption Column Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. BRICS Single Use Immunoadsorption Column Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 248. BRICS Single Use Immunoadsorption Column Market Size, by Private Hospitals, 2017-2032 (USD Million)
TABLE 249. BRICS Single Use Immunoadsorption Column Market Size, by Public Hospitals, 2017-2032 (USD Million)
TABLE 250. BRICS Single Use Immunoadsorption Column Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 251. BRICS Single Use Immunoadsorption Column Market Size, by Specialized Clinics, 2017-2032 (USD Million)
TABLE 252. G7 Single Use Immunoadsorption Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 253. G7 Single Use Immunoadsorption Column Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 254. G7 Single Use Immunoadsorption Column Market Size, by Immunoglobulin Adsorption Column, 2017-2032 (USD Million)
TABLE 255. G7 Single Use Immunoadsorption Column Market Size, by Immune Complex Adsorption Column, 2017-2032 (USD Million)
TABLE 256. G7 Single Use Immunoadsorption Column Market Size, by Lipoprotein Adsorption Column, 2017-2032 (USD Million)
TABLE 257. G7 Single Use Immunoadsorption Column Market Size, by Ligand Type, 2017-2032 (USD Million)
TABLE 258. G7 Single Use Immunoadsorption Column Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 259. G7 Single Use Immunoadsorption Column Market Size, by Application, 2017-2032 (USD Million)
TABLE 260. G7 Single Use Immunoadsorption Column Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. G7 Single Use Immunoadsorption Column Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 262. G7 Single Use Immunoadsorption Column Market Size, by Private Hospitals, 2017-2032 (USD Million)
TABLE 263. G7 Single Use Immunoadsorption Column Market Size, by Public Hospitals, 2017-2032 (USD Million)
TABLE 264. G7 Single Use Immunoadsorption Column Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 265. G7 Single Use Immunoadsorption Column Market Size, by Specialized Clinics, 2017-2032 (USD Million)
TABLE 266. NATO Single Use Immunoadsorption Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 267. NATO Single Use Immunoadsorption Column Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 268. NATO Single Use Immunoadsorption Column Market Size, by Immunoglobulin Adsorption Column, 2017-2032 (USD Million)
TABLE 269. NATO Single Use Immunoadsorption Column Market Size, by Immune Complex Adsorption Column, 2017-2032 (USD Million)
TABLE 270. NATO Single Use Immunoadsorption Column Market Size, by Lipoprotein Adsorption Column, 2017-2032 (USD Million)
TABLE 271. NATO Single Use Immunoadsorption Column Market Size, by Ligand Type, 2017-2032 (USD Million)
TABLE 272. NATO Single Use Immunoadsorption Column Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 273. NATO Single Use Immunoadsorption Column Market Size, by Application, 2017-2032 (USD Million)
TABLE 274. NATO Single Use Immunoadsorption Column Market Size, by End User, 2017-2032 (USD Million)
TABLE 275. NATO Single Use Immunoadsorption Column Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 276. NATO Single Use Immunoadsorption Column Market Size, by Private Hospitals, 2017-2032 (USD Million)
TABLE 277. NATO Single Use Immunoadsorption Column Market Size, by Public Hospitals, 2017-2032 (USD Million)
TABLE 278. NATO Single Use Immunoadsorption Column Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 279. NATO Single Use Immunoadsorption Column Market Size, by Specialized Clinics, 2017-2032 (USD Million)
TABLE 280. Global Single Use Immunoadsorption Column Market Size, by Country, 2017-2032 (USD Million)
TABLE 281. United States Single Use Immunoadsorption Column Market Size, 2017-2032 (USD Million)
TABLE 282. United States Single Use Immunoadsorption Column Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 283. United States Single Use Immunoadsorption Column Market Size, by Immunoglobulin Adsorption Column, 2017-2032 (USD Million)
TABLE 284. United States Single Use Immunoadsorption Column Market Size, by Immune Complex Adsorption Column, 2017-2032 (USD Million)
TABLE 285. United States Single Use Immunoadsorption Column Market Size, by Lipoprotein Adsorption Column, 2017-2032 (USD Million)
TABLE 286. United States Single Use Immunoadsorption Column Market Size, by Ligand Type, 2017-2032 (USD Million)
TABLE 287. United States Single Use Immunoadsorption Column Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 288. United States Single Use Immunoadsorption Column Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. United States Single Use Immunoadsorption Column Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. United States Single Use Immunoadsorption Column Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 291. United States Single Use Immunoadsorption Column Market Size, by Private Hospitals, 2017-2032 (USD Million)
TABLE 292. United States Single Use Immunoadsorption Column Market Size, by Public Hospitals, 2017-2032 (USD Million)
TABLE 293. United States Single Use Immunoadsorption Column Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 294. United States Single Use Immunoadsorption Column Market Size, by Specialized Clinics, 2017-2032 (USD Million)
TABLE 295. Canada Single Use Immunoadsorption Column Market Size, 2017-2032 (USD Million)
TABLE 296. Canada Single Use Immunoadsorption Column Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 297. Canada Single Use Immunoadsorption Column Market Size, by Immunoglobulin Adsorption Column, 2017-2032 (USD Million)
TABLE 298. Canada Single Use Immunoadsorption Column Market Size, by Immune Complex Adsorption Column, 2017-2032 (USD Million)
TABLE 299. Canada Single Use Immunoadsorption Column Market Size, by Lipoprotein Adsorption Column, 2017-2032 (USD Million)
TABLE 300. Canada Single Use Immunoadsorption Column Market Size, by Ligand Type, 2017-2032 (USD Million)
TABLE 301. Canada Single Use Immunoadsorption Column Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 302. Canada Single Use Immunoadsorption Column Market Size, by Application, 2017-2032 (USD Million)
TABLE 303. Canada Single Use Immunoadsorption Column Market Size, by End User, 2017-2032 (USD Million)
TABLE 304. Canada Single Use Immunoadsorption Column Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 305. Canada Single Use Immunoadsorption Column Market Size, by Private Hospitals, 2017-2032 (USD Million)
TABLE 306. Canada Single Use Immunoadsorption Column Market Size, by Public Hospitals, 2017-2032 (USD Million)
TABLE 307. Canada Single Use Immunoadsorption Column Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 308. Canada Single Use Immunoadsorption Column Market Size, by Specialized Clinics, 2017-2032 (USD Million)
TABLE 309. Mexico Single Use Immunoadsorption Column Market Size, 2017-2032 (USD Million)
TABLE 310. Mexico Single Use Immunoadsorption Column Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 311. Mexico Single Use Immunoadsorption Column Market Size, by Immunoglobulin Adsorption Column, 2017-2032 (USD Million)
TABLE 312. Mexico Single Use Immunoadsorption Column Market Size, by Immune Complex Adsorption Column, 2017-2032 (USD Million)
TABLE 313. Mexico Single Use Immunoadsorption Column Market Size, by Lipoprotein Adsorption Column, 2017-2032 (USD Million)
TABLE 314. Mexico Single Use Immunoadsorption C

Companies Mentioned

  • Agilent Technologies, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Avantor, Inc.
  • Bio-Rad Laboratories, Inc.
  • Corning Incorporated
  • Danaher Corporation
  • Eppendorf AG
  • Fresenius Medical Care AG & Co. KGaA
  • Fujifilm Diosynth Biotechnologies
  • GE Healthcare
  • Jafron Biomedical Co., Ltd.
  • Merck KGaA
  • POCARD Ltd.
  • Repligen Corporation
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • Waters Corporation